Tenaya Therapeutics Stock Alpha and Beta Analysis
| TNYA Stock | USD 3.57 0.28 8.51% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Tenaya Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Tenaya Therapeutics over a specified time horizon. Remember, high Tenaya Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Tenaya Therapeutics' market risk premium analysis include:
Beta 2.23 | Alpha 0.27 | Risk 7.6 | Sharpe Ratio 0.11 | Expected Return 0.81 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Tenaya |
Tenaya Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Tenaya Therapeutics market risk premium is the additional return an investor will receive from holding Tenaya Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Tenaya Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Tenaya Therapeutics' performance over market.| α | 0.27 | β | 2.23 |
Tenaya Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Tenaya Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Tenaya Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Tenaya Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Tenaya Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tenaya Therapeutics shares will generate the highest return on investment. By understating and applying Tenaya Therapeutics stock market price indicators, traders can identify Tenaya Therapeutics position entry and exit signals to maximize returns.
Tenaya Therapeutics Return and Market Media
The median price of Tenaya Therapeutics for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 2.06 with a coefficient of variation of 16.84. The daily time series for the period is distributed with a sample standard deviation of 0.36, arithmetic mean of 2.15, and mean deviation of 0.28. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Column Group Iii Gp, Lp of 2222222 shares of Tenaya Therapeutics at 4.5 subject to Rule 16b-3 | 09/26/2024 |
2 | Tenaya Therapeutics, Inc. Given Consensus Rating of Buy by Analysts | 10/10/2024 |
3 | Acquisition by Burroughs Amy L. of 34000 shares of Tenaya Therapeutics at 2.04 subject to Rule 16b-3 | 10/18/2024 |
4 | Heres Why Were Watching Tenaya Therapeutics Cash Burn Situation | 11/01/2024 |
5 | Disposition of 2258 shares by Chihiro Saito of Tenaya Therapeutics at 2.12 subject to Rule 16b-3 | 11/18/2024 |
6 | Tenaya Therapeutics Buy Rating Reiterated at HC Wainwright | 11/25/2024 |
7 | Tenaya shares retain Buy rating, price target on trial update | 11/26/2024 |
About Tenaya Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Tenaya or other stocks. Alpha measures the amount that position in Tenaya Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 11.73 | 7.99 | 4.91 | 4.66 | Net Debt To EBITDA | 0.36 | 0.7 | 0.27 | 0.26 |
Tenaya Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Tenaya Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tenaya Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Tenaya Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Tenaya Therapeutics. Please utilize our Beneish M Score to check the likelihood of Tenaya Therapeutics' management manipulating its earnings.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Tenaya Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Tenaya Therapeutics Backtesting, Tenaya Therapeutics Valuation, Tenaya Therapeutics Correlation, Tenaya Therapeutics Hype Analysis, Tenaya Therapeutics Volatility, Tenaya Therapeutics History and analyze Tenaya Therapeutics Performance. For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Tenaya Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.